BREAKING NEWS

Johnson & Johnson, US gov't expand pact for next phase of COVID-19 vaccine

By REUTERS

NOVEMBER 14, 2020 17:14

Johnson & Johnson and the US Department of Health and Human Services have expanded an agreement to support the next phase of COVID-19 vaccine candidate research and development, the company said on Saturday.

Under the agreement the company will commit approximately $604 million and the HHS Department's Biomedical Advanced Research and Development Authority will commit about $454 million to support the Phase 3 ENSEMBLE trial evaluating Janssen's investigational COVID-19 vaccine candidate as a single dose in up to 60,000 volunteers worldwide, the company said in a statement

Kenya, Somalia strengthen bilateral ties with new collaboration agreement

By THE MEDIA LINE STAFF

05/08/2024 03:54 AM

US CIA director to travel to Israel on Wednesday for talks with Netanyahu

By REUTERS

05/08/2024 12:47 AM

IDF destroys launchers responsible for and earlier attack

By MAARIV

05/07/2024 11:44 PM

Suspicious aerial target intercepted near Eilat, Israel

By MAARIV

05/07/2024 11:39 PM